WPMP-4

N/A

Report date: 2025/01/26 17:07:44

Base Information

Drug NameWPMP-4
Drug Alias NameAnti-mIgM Monoclonal Antibody (Welt Bio-molecular Pharmaceutical/University of California)Anti-BCRC Monoclonal Antibody (Welt Bio-molecular Pharmaceutical/University of California)WPMP-4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunoglobulin M inhibitors
TargetsImmunoglobulin M
Therapy Area/IndicationsHematologic NeoplasmsLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesWelt Bio-Molecular Pharmaceutical LlcUniversity of California Irvine
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A